VANCOUVER, BC — Virogin Biotech, a clinical-stage biotech company, today announced that the first patient has been dosed in its Phase 1 clinical study evaluating VG201, a first-in-class HSV Type I… Read More
OTTAWA, ON – The Health Research Foundation (HRF) of Innovative Medicines Canada is pleased to announce that Dr. Allison McGeer is the recipient of its distinguished Medal of Honour. Dr…. Read More
Response Biomedical Corp. (Response), a global provider of acute care diagnostic testing solutions, is announcing today that Health Canada has granted the RAMP® COVID-19 Antigen Test authorization to commercialize under the… Read More
Phase III GRADUATE studies did not meet their primary endpoints of slowing clinical decline in people with early Alzheimer’s The level of beta-amyloid removal by gantenerumab was lower than expected Topline data… Read More
OTTAWA, ON – Innovative Medicines Canada (IMC) is calling on Health Canada to direct the Patented Medicine Prices Review Board (PMPRB) to suspend its current Guidelines consultation process. If the PMPRB’s… Read More
